Cauda equina syndrome is a potentially devastating condition caused by compression of the cauda equina nerve roots. This can result in bowel, bladder and sexual dysfunction plus lower limb weakness, numbness, and pain. Cauda equina syndrome occurs infrequently but has serious potential morbidity and medico-legal consequences. This study aims to identify and describe the presentation and management of patients with cauda equina syndrome in the United Kingdom using trainee research collaborative networks. This will provide accurate incidence figures, establish current clinical practice, allow assessment of the adherence to national published standards of care, and determine patient outcomes from this condition. Accurate, up to date information about the presentation, management, and outcome of patients with cauda equina syndrome will inform standards of service design and delivery for this important but infrequent condition and help to identify future research priorities.
Understanding Cauda Equina Syndrome (UCES) is a prospective cohort study of patients with confirmed CES managed at specialist spinal centres in the UK. Cases will be identified by neurosurgical or orthopaedic trainees in each specialist centre through daily screening of tertiary referrals and admissions to specialist spinal services. All patients managed as CES by the treating team will be included in this audit. CES will be divided into CES suspected (CESS), CES incomplete (CESI), and CES retention (CESR). Data regarding timing and type of symptom onset, referral, investigation, management, and outcome will be recorded anonymously on a secure database by the local trainee investigator during the patient's hospital admission and after discharge. Patient consent will be sought for the use of their data and patients will be asked to complete patient reported outcome measures representing their condition before surgery and up to one year after surgery. This data will be compared with care quality statements and published outcome data for CES. The study will recruit for one year. Cases will be identified from admissions to spinal units between 1st June 2018 until 31st May 2019. The last one year follow up assessments will be sent to participants on 1st June 2020. This is an observational study. No changes to routine patient care will occur during this study.
Study Type
OBSERVATIONAL
Enrollment
621
Department of Neurosciences, Western General Hospital
Edinburgh, United Kingdom
Identify the number of cases of Cauda Equina Syndrome (CES) in the UK in all collaborating centres
Cases will be identified by neurosurgical or orthopaedic trainees in each specialist centre through daily screening of tertiary referrals and admissions to specialist spinal services. All patients managed as CES by the treating team will be counted.
Time frame: June 2018-June 2021
Describe the presenting symptoms and signs in patients with CES
Study participants who have consented to participate will also be asked to fill out details about their patient journey to the spinal unit, their symptoms, patient reported outcome measures, and service usage. These will be collected electronically anonymously via the electronic database and linked to the patient record.
Time frame: June 2018-June 2021
Describe the pathways of presentation to specialist spinal services for patients with CES in the UK and Ireland
Patients will be asked about their care pathway prior to and after entering hospital
Time frame: June 2018-June 2021
Describe the type and timing of investigation of patients with CES
Timing of MRI scans will be gathered by a member of the local clinical care team. Time will be divided into hours from symptom onset (patient and clinician rated).
Time frame: June 2018-June 2021
Describe the medical and surgical management of CES
Type and timing of medical or surgical management of patients with cauda equina syndrome will be gathered by a member of the local clinical care team. Time will be divided into hours from symptom onset (patient and clinician rated), type will be a drop down menu of various types of operation and 'other' with room for explanation.
Time frame: June 2018- June 2021
Describe clinical outcomes for patients with CES using validated patient reported outcome measures, stratified by presentation, investigations, and management
Patient reported outcome measures will be used such as the ODI.
Time frame: June 2018-June 2021
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.